Clario at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
Clario takes part in 5 sessions at CTAD 2026 in Boston. Its program centres on the quality of clinical trial endpoints, from Clinical Dementia Rating scoring to MRI volume measures. Its work covers rater performance, machine learning for error detection and the sensitivity of ADAS-Cog versions in early disease.
| Organization | CTAD 2026 Attendance |
|---|---|
Clario Philadelphia, Pennsylvania | ◇Silver Sponsor |
Provides eCOA, medical imaging and other endpoint data technology for clinical trials; part of Thermo Fisher Scientific. | Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Thu Nov 19 7:15am–5:00pm Poster Thu Nov 19 7:15am–5:00pm |
Instantly find 20 buyers from Clario
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction